Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer

• Andrea Gombos,
• David Venet,
• Lieveke Ameye,
• Peter Vuylsteke,
• Patrick Neven,
• Vincent Richard,
• Francois P. Duhoux,
• Jean-Francois Laes,
• Françoise Rothe,
• Christos Sotiriou,
• Marianne Paesmans,
• Ahmad Awada,
• Thomas Guiot,
• Patrick Flamen,
• Martine Piccart-Gebhart,
• Michail Ignatiadis,
• Géraldine Gebhart

Affiliations

Andrea Gombos

Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB)

David Venet

Université Libre de Bruxelles

Lieveke Ameye

Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB)

Peter Vuylsteke

Medical Oncology, UCLouvain, CHU Namur Site Sainte-Elisabeth

Patrick Neven

Multidisciplinary Breast Center and Department of Gynecology and Obstetrics, UZ Leuven, KU Leuven

Vincent Richard

Medical Oncology CHU Ambroise Paré

Francois P. Duhoux

Medical Oncology Cliniques Universitaires Saint-Luc

Jean-Francois Laes

OncoDNA

Françoise Rothe

Université Libre de Bruxelles

Christos Sotiriou

Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB)

Marianne Paesmans

Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB)

Ahmad Awada

Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB)

Thomas Guiot

Nuclear Medicine, Institut Jules Bordet

Patrick Flamen

Nuclear Medicine, Institut Jules Bordet

Martine Piccart-Gebhart

Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB)

Michail Ignatiadis

Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB)

Géraldine Gebhart

Nuclear Medicine, Institut Jules Bordet